116 related articles for article (PubMed ID: 9065878)
1. Striatal dopamine D1 receptors in narcolepsy: a PET study with [11C]NNC 756.
Rinne JO; Hublin C; Partinen M; Ruottinen H; Någren K; Lehikoinen P; Ruotsalainen U; Laihinen A
J Sleep Res; 1996 Dec; 5(4):262-4. PubMed ID: 9065878
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography study of human narcolepsy: no increase in striatal dopamine D2 receptors.
Rinne JO; Hublin C; Partinen M; Ruottinen H; Ruotsalainen U; Någren K; Lehikoinen P; Laihinen A
Neurology; 1995 Sep; 45(9):1735-8. PubMed ID: 7675236
[TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine D2 receptors in patients with narcolepsy measured with PET and 11C-raclopride.
Khan N; Antonini A; Parkes D; Dahlitz MJ; Meier-Ewert K; Weindl A; Leenders KL
Neurology; 1994 Nov; 44(11):2102-4. PubMed ID: 7969966
[TBL] [Abstract][Full Text] [Related]
4. PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD.
Kemppainen N; Ruottinen H; Nâgren K; Rinne JO
Neurology; 2000 Jul; 55(2):205-9. PubMed ID: 10908891
[TBL] [Abstract][Full Text] [Related]
5. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK
Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
[TBL] [Abstract][Full Text] [Related]
7. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease.
Weeks RA; Piccini P; Harding AE; Brooks DJ
Ann Neurol; 1996 Jul; 40(1):49-54. PubMed ID: 8687191
[TBL] [Abstract][Full Text] [Related]
8. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum.
Drevets WC; Price JC; Kupfer DJ; Kinahan PE; Lopresti B; Holt D; Mathis C
Neuropsychopharmacology; 1999 Dec; 21(6):694-709. PubMed ID: 10633475
[TBL] [Abstract][Full Text] [Related]
9. Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [11C]raclopride.
Rinne JO; Laihinen A; Ruottinen H; Ruotsalainen U; Någren K; Lehikoinen P; Oikonen V; Rinne UK
J Neurol Sci; 1995 Oct; 132(2):156-61. PubMed ID: 8543941
[TBL] [Abstract][Full Text] [Related]
10. Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.
Halldin C; Foged C; Chou YH; Karlsson P; Swahn CG; Sandell J; Sedvall G; Farde L
J Nucl Med; 1998 Dec; 39(12):2061-8. PubMed ID: 9867142
[TBL] [Abstract][Full Text] [Related]
11. Neurochemical evidence supporting dopamine D1-D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation.
Rico AJ; Dopeso-Reyes IG; Martínez-Pinilla E; Sucunza D; Pignataro D; Roda E; Marín-Ramos D; Labandeira-García JL; George SR; Franco R; Lanciego JL
Brain Struct Funct; 2017 May; 222(4):1767-1784. PubMed ID: 27612857
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography shows reduced striatal dopamine D1 but not D2 receptors in juvenile neuronal ceroid lipofuscinosis.
Rinne JO; Ruottinen HM; Någren K; Aberg LE; Santavuori P
Neuropediatrics; 2002 Jun; 33(3):138-41. PubMed ID: 12200743
[TBL] [Abstract][Full Text] [Related]
13. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
Tedroff J; Pedersen M; Aquilonius SM; Hartvig P; Jacobsson G; Långström B
Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494
[TBL] [Abstract][Full Text] [Related]
14. Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET.
Rosa-Neto P; Doudet DJ; Cumming P
Neuroimage; 2004 Jul; 22(3):1076-83. PubMed ID: 15219579
[TBL] [Abstract][Full Text] [Related]
15. Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.
Hagelberg N; Kajander JK; Någren K; Hinkka S; Hietala J; Scheinin H
Synapse; 2002 Jul; 45(1):25-30. PubMed ID: 12112410
[TBL] [Abstract][Full Text] [Related]
16. Striatal dopaminergic system in dopa-responsive dystonia: a multi-tracer PET study shows increased D2 receptors.
Rinne JO; Iivanainen M; Metsähonkala L; Vainionpää L; Pääkkönen L; Någren K; Helenius H
J Neural Transm (Vienna); 2004 Jan; 111(1):59-67. PubMed ID: 14714216
[TBL] [Abstract][Full Text] [Related]
17. Unchanged striatal dopamine transporter availability in narcolepsy: a PET study with [11C]-CFT.
Rinne JO; Hublin C; Någren K; Helenius H; Partinen M
Acta Neurol Scand; 2004 Jan; 109(1):52-5. PubMed ID: 14653850
[TBL] [Abstract][Full Text] [Related]
18. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP
Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
[TBL] [Abstract][Full Text] [Related]
19. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
Brooks DJ; Ibanez V; Sawle GV; Playford ED; Quinn N; Mathias CJ; Lees AJ; Marsden CD; Bannister R; Frackowiak RS
Ann Neurol; 1992 Feb; 31(2):184-92. PubMed ID: 1575457
[TBL] [Abstract][Full Text] [Related]
20. D2 receptor binding in dopa-responsive dystonia.
Künig G; Leenders KL; Antonini A; Vontobel P; Weindl A; Meinck HM
Ann Neurol; 1998 Nov; 44(5):758-62. PubMed ID: 9818931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
